The global landscape of reproductive healthcare is undergoing a major shift. In a significant move for telehealth and reproductive autonomy, the international feminist organization Women Help Women has started manufacturing its own independent combination packs of abortion pills. By bypassing traditional pharmaceutical companies and working directly with drugmakers in India, the organization aims to secure supply chains, lower costs, and protect women from political and market vulnerabilities.

Since its launch in 2014, Women Help Women has assisted over 100,000 women globally, currently serving around 20,000 individuals annually. This new initiative marks a transition from simple distribution to direct ownership of the means of production.

Re-engineering the Product for Real Needs

The newly designed blister packs introduce several key changes based directly on feedback from users, diverging from standard pharmaceutical offerings:

• More Medication: Standard commercial packs contain one mifepristone pill and four misoprostol pills. The new feminist combipack includes eight misoprostol pills. This extra dose aligns with World Health Organization guidelines, offering users reassurance and ensuring a complete process without requiring extra medical visits.

• Reduced Costs: By cutting out corporate middlemen, the organization reduces the production cost of the medications by at least 25 percent, making the service more sustainable.

• Eco-Friendly and Discrete Design: The packaging has been minimized. It uses 30 percent less plastic, weighs 40 percent less, and occupies half the physical space of standard packaging. This reduces the carbon footprint during transport and makes mailing highly discrete.

Subverting Traditional Control

For decades, access to medical abortion has been heavily managed by pharmaceutical corporations and institutional healthcare systems. Leaders of the organization state that this move is a necessary step toward the demedicalization and decriminalization of abortion, turning a clinical service into an act of personal autonomy.

The distribution of these new combipacks began in Europe, with a primary focus on Poland, where domestic laws are highly restrictive. The rollout is expanding to sub-Saharan Africa through a partnership with the MAMA network, which connects 70 organizations across 27 countries. While the group does not currently ship pills to the United States, they manage an informational project called SASS (Self-Managed Abortion. Safe and Supported) and have indicated readiness to expand direct services if political restrictions tighten further.

This article is based on original reporting. You can read the comprehensive report in the original English text on Ms. Magazine